Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsNASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for TCBS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
quarterly dividend at or above $0.06 | A supporting condition in Texas Community Bancshares Inc's published investment case. The stated target is quarterly dividend >= $0.06. | Intact | dividend falls below $0.06 per quarter | Dividend per share: $0.06 per share FY2026-Q2; GAAP. Published target: quarterly dividend >= $0.06. Target period is not explicitly aligned with this observation. Aug 11, 20260.06 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
TCBS is a small-bank growth and expansion story, not yet a proven durable compounder: the evidence shows recent profits and improving margins, but the earnings-quality label remains loss-making. The long-term thesis is on watch, with medium confidence, and recent performance is below its industry cohort.
The valuation signals are mixed: TCBS is tagged as stretched, with a sizable peer premium, even though the valuation divergence driver says cheap versus peers. The expectations gap is 0.22, but the snapshot does not explain its scale or direction, so what the market already assumes is unclear.
Recent results show modest improvement: second-quarter 2026 revenue and net income were higher than first-quarter figures, while comparable first-quarter net interest income and margin also improved year over year. Management is expanding through the SJCB merger and Terrell entry, and is investing in banking technology, but the contribution of expansion is not isolated and technology expense increased. Near term, guidance cuts and falling rates are risks; confidence has also moved from high to medium.
The multi-year view depends on whether management can grow in markets it knows while sustaining loan and margin progress and eventually showing efficiency gains from technology. Near term, a guidance cut or rate cuts would weaken the setup, while continued strong results and higher guidance from sector bellwethers could support sector momentum.
Over the next 1 to 3 years, TCBS has evidence of improving operating results and concrete expansion, but elevated risk, below-cohort performance, and stretched pricing keep the thesis on watch. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Its free cash flow yield is 5%, supporting steady returns. |
| Broken |
| free cash flow yield falls below 5% |
Free cash flow yield: 2.36% As of 2026-11-04; trailing twelve months. The target timing and basis require a separate assessment. Nov 4, 20262.36 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
maintain stable profit margins supporting EPS of $0.22+ | A primary condition in Texas Community Bancshares Inc's published investment case. The stated target is EPS >= $0.22 per share. | Intact | EPS falls below $0.22 per share in FY25 | Diluted EPS: $0.35 per share FY2026-Q2; GAAP. Published target: EPS >= $0.22 per share. Annual target cannot be compared with a quarterly or TTM observation. Aug 11, 20260.35 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
annual revenue growth of about 11% | A primary condition in Texas Community Bancshares Inc's published investment case. The stated target is >=10.7% YoY. | Intact | YoY revenue growth falls below 10.7% next year | Revenue growth: 6.39% FY2026-Q2; GAAP. Published target: >=10.7% YoY. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. Aug 11, 20266.393862 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 6, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.